Vicor CEO sells 20,000 shares under 10b5-1 plan
VICOR CORP Chairman and CEO Patrizio Vinciarelli reported open-market sales of 20,000 shares of common stock on May 28, 2026.
Rhea-AI Filing Summary
VICOR CORP Chairman and CEO Patrizio Vinciarelli reported open-market sales of 20,000 shares of common stock on May 28, 2026. The sales were executed in 19 separate transactions at weighted average prices within ranges from about $328.10 to $350.43, as detailed in the filing.
The transactions were effected pursuant to a pre-arranged Rule 10b5-1 trading plan adopted on February 26, 2026. Following these sales, Vinciarelli directly holds 8,828,090 shares of VICOR CORP common stock and indirectly holds 167,125 shares as trustee of an irrevocable trust established for the benefit of his child.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 600 | $328.3733 | $197K |
| Sale | Common Stock | 400 | $330.25 | $132K |
| Sale | Common Stock | 900 | $333.4761 | $300K |
| Sale | Common Stock | 700 | $334.3086 | $234K |
| Sale | Common Stock | 420 | $335.7637 | $141K |
| Sale | Common Stock | 1,303 | $336.6774 | $439K |
| Sale | Common Stock | 477 | $337.9609 | $161K |
| Sale | Common Stock | 1,000 | $339.024 | $339K |
| Sale | Common Stock | 600 | $340.2517 | $204K |
| Sale | Common Stock | 1,049 | $341.3245 | $358K |
| Sale | Common Stock | 2,756 | $342.4912 | $944K |
| Sale | Common Stock | 1,795 | $343.1585 | $616K |
| Sale | Common Stock | 1,300 | $344.4492 | $448K |
| Sale | Common Stock | 530 | $345.531 | $183K |
| Sale | Common Stock | 1,670 | $346.5091 | $579K |
| Sale | Common Stock | 1,700 | $347.4478 | $591K |
| Sale | Common Stock | 2,400 | $348.5783 | $837K |
| Sale | Common Stock | 200 | $349.175 | $70K |
| Sale | Common Stock | 200 | $350.42 | $70K |
| holding | Common Stock | -- | -- | -- |
Footnotes (21)
- F1. These shares are held by the reporting person as Trustee of the Patrizio Vinciarelli Irrevocable Trust U/A Dated 12/21/2012, established for the benefit of the child of the reporting person.
- F2. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 26, 2026.
- F3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $328.1000 to $328.7100. The reporting person undertakes to provide to Vicor Corporation, any security holder of Vicor Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (21) to this Form 4.
- F4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $330.1800 to $330.3800.
- F5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $332.7800 to $333.7500.
- F6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $333.7900 to $334.6800.
- F7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $335.2600 to $336.2100.
- F8. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $336.2800 to $337.2400.
- F9. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $337.4000 to $338.3300.
- F10. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $338.5700 to $339.5400.
- F11. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $339.6200 to $340.6100.
- F12. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $340.7000 to $341.6800.
- F13. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $341.7300 to $342.7200.
- F14. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $342.7400 to $343.5200.
- F15. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $344.0200 to $344.8600.
- F16. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $345.0200 to $346.0100.
- F17. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $346.0300 to $346.8750.
- F18. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $347.0400 to $347.9800.
- F19. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $348.0700 to $349.0200.
- F20. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $349.1500 to $349.2000.
- F21. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $350.4100 to $350.4300.
Key Figures
Key Terms
Rule 10b5-1 trading plan financial
Irrevocable Trust U/A financial
weighted average price financial
open-market sale financial
indirect ownership financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did VICR Chairman and CEO Patrizio Vinciarelli report?
Were the May 28, 2026 VICR insider sales under a Rule 10b5-1 plan?
How many sale transactions did VICR’s CEO report on May 28, 2026?
AI-generated analysis. How Rhea-AI works. Not financial advice.